Momegalen (Mometasone Furoate)

Mometasone furoate, the active ingredient in Momegalen, is a corticosteroid (glucocorticoid) presented as a topical formulation for cutaneous use. It is prescribed to reduce inflammation and allergic responses in various skin conditions. GNH USA supplies Momegalen as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Momegalen, a topical glucocorticoid, is employed to manage inflammatory skin disorders. - Atopic dermatitis: reduces redness, swelling and itching associated with the condition. - Psoriasis: diminishes plaque formation and scaling. - Seborrheic dermatitis: controls flaking and erythema on scalp and face. - Contact dermatitis: alleviates irritation caused by allergens or irritants.

Adverse reactions may occur with topical use of Momegalen.

Common Side Effects: - Burning or stinging sensation at the application site - Pruritus or mild itching - Dryness or flaking of the skin - Erythema or mild redness - Folliculitis or acneiform eruptions - Mild irritation or tingling

Serious or Rare Side Effects: - Skin atrophy or thinning - Hypopigmentation or depigmentation - Allergic contact dermatitis - Secondary bacterial, fungal or viral infection - Systemic cortisol suppression with extensive use - Delayed wound healing or ulceration

Before using Momegalen, consider the following safety measures. - Pregnancy: consult a healthcare professional before application. - Breastfeeding: discuss potential risks with a physician. - Children: use only under medical supervision, especially on large body areas. - Infected or ulcerated skin: avoid application unless directed by a clinician. - Occlusive dressings: do not cover treated area unless specifically advised. - Store at room temperature: keep in the original container, protect from moisture and light.

Momegalen may interact with other medications or substances.

Major Interactions (Avoid): - Systemic corticosteroids: increased risk of systemic glucocorticoid effects. - Antifungal agents (e.g., ketoconazole): may enhance percutaneous absorption. - Live vaccines: topical steroids can reduce vaccine efficacy.

Moderate Interactions (Monitor Closely): - NSAIDs: potential for additive skin irritation. - Antihistamines: may mask local irritation signs. - Photosensitizing agents: heightened risk of photosensitivity reactions.